Cargando…
Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
BACKGROUND: Nephrolithiasis in allograft kidneys is rare, but this diagnosis may lead to allograft complications and patient morbidity. Previous studies that have evaluated nephrolithiasis posttransplant have focused on surgical stone management, with limited data on urine metabolic risk factors and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862062/ https://www.ncbi.nlm.nih.gov/pubmed/35211306 http://dx.doi.org/10.1093/ckj/sfab208 |
_version_ | 1784654990061600768 |
---|---|
author | Bolen, Erin Stern, Karen Humphreys, Mitchell Brady, Alexandra Leavitt, Todd Zhang, Nan Keddis, Mira |
author_facet | Bolen, Erin Stern, Karen Humphreys, Mitchell Brady, Alexandra Leavitt, Todd Zhang, Nan Keddis, Mira |
author_sort | Bolen, Erin |
collection | PubMed |
description | BACKGROUND: Nephrolithiasis in allograft kidneys is rare, but this diagnosis may lead to allograft complications and patient morbidity. Previous studies that have evaluated nephrolithiasis posttransplant have focused on surgical stone management, with limited data on urine metabolic risk factors and the presence of stones after follow-up. METHODS: We retrospectively evaluated kidney transplant recipients who were diagnosed with transplant nephrolithiasis between 2009 and 2019. Computed tomography and ultrasound imaging were used to confirm stone presence. RESULTS: The incidence of allograft kidney stone formation was 0.86% of 6548 kidney transplant recipients. Of the 56 cases identified, 17 (30%) had a pretransplant history of nephrolithiasis. Only four (7%) patients received a known kidney stone at the time of allograft implantation. Of the 56 cases, 34 had a 24-h supersaturation study. The urine supersaturation study showed 32 patients (94%) had a urine citrate of <450 mg excreted in 24 h (median 124.5 mg/24 h, reference range >500 mg/24 h), along with 22 patients (61%) having a urine oxalate excretion of ≥30 mg in 24 h (median 34.4 mg/24 h, reference range <30 mg/24 h). Calcium oxalate composition was most common (91% with >1 supersaturation for calcium oxalate crystals), with normal median urine calcium levels (median urine calcium 103.5 mg/24 h, reference range <200 mg/24 h). After a 4-year follow-up, 50% (n = 28) required surgical intervention and 43 (77%) patients continued to have evidence of transplant nephrolithiasis on imaging. CONCLUSIONS: This is the largest study of transplant nephrolithiasis confirming that hypocitraturia and hyperoxaluria were the most significant urine metabolic risk factors associated with allograft nephrolithiasis and that hyperoxaluria was the most prevalent driver for calcium oxalate stone composition. Our study is first to show low stone-free rates at the last follow-up and a significant proportion requiring surgical intervention. |
format | Online Article Text |
id | pubmed-8862062 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88620622022-02-23 Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis Bolen, Erin Stern, Karen Humphreys, Mitchell Brady, Alexandra Leavitt, Todd Zhang, Nan Keddis, Mira Clin Kidney J Original Article BACKGROUND: Nephrolithiasis in allograft kidneys is rare, but this diagnosis may lead to allograft complications and patient morbidity. Previous studies that have evaluated nephrolithiasis posttransplant have focused on surgical stone management, with limited data on urine metabolic risk factors and the presence of stones after follow-up. METHODS: We retrospectively evaluated kidney transplant recipients who were diagnosed with transplant nephrolithiasis between 2009 and 2019. Computed tomography and ultrasound imaging were used to confirm stone presence. RESULTS: The incidence of allograft kidney stone formation was 0.86% of 6548 kidney transplant recipients. Of the 56 cases identified, 17 (30%) had a pretransplant history of nephrolithiasis. Only four (7%) patients received a known kidney stone at the time of allograft implantation. Of the 56 cases, 34 had a 24-h supersaturation study. The urine supersaturation study showed 32 patients (94%) had a urine citrate of <450 mg excreted in 24 h (median 124.5 mg/24 h, reference range >500 mg/24 h), along with 22 patients (61%) having a urine oxalate excretion of ≥30 mg in 24 h (median 34.4 mg/24 h, reference range <30 mg/24 h). Calcium oxalate composition was most common (91% with >1 supersaturation for calcium oxalate crystals), with normal median urine calcium levels (median urine calcium 103.5 mg/24 h, reference range <200 mg/24 h). After a 4-year follow-up, 50% (n = 28) required surgical intervention and 43 (77%) patients continued to have evidence of transplant nephrolithiasis on imaging. CONCLUSIONS: This is the largest study of transplant nephrolithiasis confirming that hypocitraturia and hyperoxaluria were the most significant urine metabolic risk factors associated with allograft nephrolithiasis and that hyperoxaluria was the most prevalent driver for calcium oxalate stone composition. Our study is first to show low stone-free rates at the last follow-up and a significant proportion requiring surgical intervention. Oxford University Press 2021-10-20 /pmc/articles/PMC8862062/ /pubmed/35211306 http://dx.doi.org/10.1093/ckj/sfab208 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Bolen, Erin Stern, Karen Humphreys, Mitchell Brady, Alexandra Leavitt, Todd Zhang, Nan Keddis, Mira Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
title | Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
title_full | Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
title_fullStr | Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
title_full_unstemmed | Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
title_short | Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
title_sort | urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862062/ https://www.ncbi.nlm.nih.gov/pubmed/35211306 http://dx.doi.org/10.1093/ckj/sfab208 |
work_keys_str_mv | AT bolenerin urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis AT sternkaren urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis AT humphreysmitchell urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis AT bradyalexandra urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis AT leavitttodd urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis AT zhangnan urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis AT keddismira urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis |